Molecular Partners
@MolecularPrtnrs
Followers
452
Following
38
Media
390
Statuses
496
Pioneers in a new class of custom-built drugs – DARPin therapeutics. Focus areas: oncology, radiopharma, protein engineering, creating a positive culture. $MOLN
Joined March 2020
We’ve been in Boston with the Venture Leaders Biotech teams - a selection of the most promising Swiss based biotech startups attending a global business development and investor roadshow. #Cancer #Oncology #Radiotherapy #DARPin #RadioDARPin #Investing .
linkedin.com
Seth Lewis is on the road this week with the Venture Leaders teams. Molecular Partners is sponsoring Venture Leaders Biotech, a selection of the most promising Swiss-based biotech startups which...
0
0
1
We and our strategic partner Orano Med are pleased to announce the debut of MP0726, our Radio-DARPin candidate targeting mesothelin (MSLN) - and to present preclinical data at SNMMI tomorrow. #Cancer #Oncology #Radiotherapy #DARPin #RadioDARPin.
investors.molecularpartners.com
MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano Med Promising tumor...
0
0
0
We had a great time this weekend taking part in the Sola Run Zurich! Our 14-member running team tackled a challenging 115 km course. #SOLAStafette #TeamSpirit #CommunityEngagement #CompanyPride #ZurichEvents #SwissSports.
0
0
0
We had the privilege to present not just once, but twice, at the 2025 PEGS Boston Summit. #PEGSBostonSummit #Biotech #DARPin #RadioDARPin #Innovation #Science.
linkedin.com
We had the privilege to present not just once, but twice, at the 2025 PEGS Boston Summit Christian Reichen, Director Oncology Research, presented on our Radio-DARPins, including our first program...
0
0
0
Swiss Biotech Day 2025 was a great opportunity to connect with thought-leaders, partners, investors, media and other stakeholders and share insights. #SwissBiotechDay #SBD2025 #Biotech #Conference #Investing #Radiotherapy #DARPin #RadioDARPin.
linkedin.com
Swiss Biotech Day 2025 was – as always – a great opportunity to connect with thought-leaders, partners, investors, media and other stakeholders and share insights. A heartfelt thank you to Swiss...
0
0
0
We’re looking forward to hosting and participating in a panel discussion on Radioligand therapies at Swiss Biotech Day, on Tuesday May 6 at 15:00-15:45. 👉 #SwissBiotechDay #SBD2025 #Biotech #Conference #Investing #Radiotherapy #DARPin #RadioDARPin
0
0
1
We have a lot going on today at Swiss Biotech Day! Check out the details below. #SwissBiotechDay #SBD2025 #Networking #Biotech #Conference #Investing #Radiotherapy #DARPin #RadioDARPin
0
0
0
We had the pleasure of hosting 55 talented biotechnology students from ZHAW, who are exploring future career opportunities. #Biotech #Careers #Students #Innovation #DARPin #RadioDARPin.
linkedin.com
We had the pleasure of hosting 55 talented biotechnology students from ZHAW Zurich University of Applied Sciences, who are on the cusp of completing their degrees and exploring future career opport...
0
0
0
The DARPin modality underpins our Switch-DARPin pipeline, through which we are opening doors to treat diseases with precision and efficiency. We presented on it at #AACR2025. #Biotech #Innovation #Cancer #DARPin #NextGenMedicine
0
0
1
On AML World Awareness Day, we stand united to shine a light on Acute Myeloid Leukemia (AML), a challenging and aggressive form of blood cancer. 👉
0
0
0
We were delighted to welcome shareholders to our Annual General Meeting (AGM) today. All resolutions were approved. 👉 #AGM2025 #Biotech #Innovation #ShareholderSupport #DARPin #RadioDARPin
0
0
0
Molecular Partners will be attending Swiss Biotech Day on May 6, 2025! We are a sponsor of this event, which is a fantastic opportunity to connect. 👉 #SwissBiotechDay #SBD2025 #Networking #Biotech #Conference #Investing #Radiotherapy #DARPin #RadioDARPin
0
0
0
Our Radio-#DARPin platform delivers radioactive payloads directly to solid tumors. Don’t miss our presentation on targeting mesothelin (MSLN) at #AACR2025!. 👉 #Biotech #Innovation #Cancer #NextGenMedicine
0
0
0
Molecular Partners’ exclusive strategic partnership with @OranoMed on Radio-DARPins is particularly powerful. Find out more and look out for our upcoming presentation at #AACR2025. 👉 #Radiotherapy #RadioDARPins #NextGenMedicine #Biotech #Cancer
0
0
0
Our CEO Patrick Amstutz will be taking part in a panel discussion on radiopharmaceuticals at the Van Lanschot Kempen Life Sciences Conference, on April 3 at 10:30am CET. #Cancer #Oncology #Biotech #Investing #DARPin #RadioDARPin
0
0
1
Join us in Chicago at the American Association for Cancer Research (AACR) Annual Meeting 2025, from April 25-30!. 👉 #Cancer #Oncology #AACR2025 #DARPin #RadioDARPin
0
1
0
A big thank you to everyone who attended and engaged with us at the Fourth Transatlantic Exchange in Oncology this week – particularly around our presentation on scaling up the Radio-DARPin platform with Orano Med. #Investing #Conferences #Oncology #Cancer #DARPin #RadioDARPin
0
0
0
We’re looking forward to presenting at the Fourth Transatlantic Exchange in Oncology, which takes place in Paris on Wednesday March 19. 👉 #Investing #Conferences #Oncology #Cancer #DARPin #RadioDARPin
0
0
0
We’ve just released our financial results and Annual Report for 2024!. 👉 #Financials #FinancialResults #AR2024 #Oncology #Cancer #DARPin #RadioDARPin
0
0
0
Continuing our women in STEM series, today we are spotlighting Joanna Robinson and what drives her passion for oncology research. 👉 #WomenInSTEM #Cancer #IWD2025 #InternationalDayOfWomenAndGirlsInScience
0
0
0